

BMS202 hydrochloride (1675203-84-5(free base))
CAS No. 2089334-95-0
BMS202 hydrochloride (1675203-84-5(free base)) ( —— )
产品货号. M35287 CAS No. 2089334-95-0
BMS202 hydrochloride (1675203-84-5(free base)) (PD-1/PD-L1 inhibitor 2 hydrochloride) is a small-molecule PD-1/PD-L1 interaction inhibitor (IC50: 18 nM). Biophysical studies demonstrate that BMS202 binds directly to PD-L1. Binding of BMS202 promotes PD-L1 dimerisation and blocks the PD-L1/ PD1 interaction.
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥607 | 有现货 |
![]() ![]() |
5MG | ¥824 | 有现货 |
![]() ![]() |
10MG | ¥1316 | 有现货 |
![]() ![]() |
25MG | ¥2526 | 有现货 |
![]() ![]() |
50MG | ¥4512 | 有现货 |
![]() ![]() |
100MG | ¥6319 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称BMS202 hydrochloride (1675203-84-5(free base))
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述BMS202 hydrochloride (1675203-84-5(free base)) (PD-1/PD-L1 inhibitor 2 hydrochloride) is a small-molecule PD-1/PD-L1 interaction inhibitor (IC50: 18 nM). Biophysical studies demonstrate that BMS202 binds directly to PD-L1. Binding of BMS202 promotes PD-L1 dimerisation and blocks the PD-L1/ PD1 interaction.
-
产品描述BMS202 hydrochloride (1675203-84-5(free base)) (PD-1/PD-L1 inhibitor 2 hydrochloride) is a small-molecule PD-1/PD-L1 interaction inhibitor (IC50: 18 nM). Biophysical studies demonstrate that BMS202 binds directly to PD-L1. Binding of BMS202 promotes PD-L1 dimerisation and blocks the PD-L1/ PD1 interaction.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Immunology/Inflammation
-
靶点PD-1/PD-L1
-
受体PD-1/PD-L1
-
研究领域——
-
适应症——
化学信息
-
CAS Number2089334-95-0
-
分子量455.97
-
分子式C25H30ClN3O3
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCl.COc1nc(OCc2cccc(c2C)-c2ccccc2)ccc1CNCCNC(C)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册




关联产品
-
(D)-PPA 1
PD-1/PD-L1 interaction inhibitor. Binds to PD-L1 (Kd = 0.51 μM). Inhibits interaction at 1 mg/mL in flow cytometry. Inhibits tumor growth and prolongs survival time of mice in vivo.
-
BMS-200
一种有效的 PD-1/PD-L1 相互作用抑制剂,在同质时间分辨荧光结合测定中 IC50 为 80 nM。
-
Nofazinlimab
Nofazinlimab (CS1003) 是一种人源 IgG4 抗 PD-1 单克隆抗体。Nofazinlimab 可用于不可切除肝细胞癌 (uHCC) 的研究。